EE200300456A - Indolopürrolokarbasoolide topoisomeraas I selektiivsed tsütotoksilised suhkruderivaadid ning nende kasutamine - Google Patents

Indolopürrolokarbasoolide topoisomeraas I selektiivsed tsütotoksilised suhkruderivaadid ning nende kasutamine

Info

Publication number
EE200300456A
EE200300456A EEP200300456A EEP200300456A EE200300456A EE 200300456 A EE200300456 A EE 200300456A EE P200300456 A EEP200300456 A EE P200300456A EE P200300456 A EEP200300456 A EE P200300456A EE 200300456 A EE200300456 A EE 200300456A
Authority
EE
Estonia
Prior art keywords
indolopyrrolocarbazoles
topoisomerase
sugar derivatives
selective cytotoxic
cytotoxic
Prior art date
Application number
EEP200300456A
Other languages
English (en)
Estonian (et)
Inventor
H. Ruediger Edward
G. Saulnier Mark
Beaulieu Francis
Bachand Carol
Balusubramanian Neelakantan
Hepler Long Byron
B. Frennesson David
Zimmerman Kurt
B. Naidu Narasimhulu
M. Stoffan Karen
Robert St. Laurent Denis
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of EE200300456A publication Critical patent/EE200300456A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
EEP200300456A 2001-03-22 2002-03-22 Indolopürrolokarbasoolide topoisomeraas I selektiivsed tsütotoksilised suhkruderivaadid ning nende kasutamine EE200300456A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27804301P 2001-03-22 2001-03-22
PCT/US2002/008819 WO2002077255A1 (en) 2001-03-22 2002-03-22 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles

Publications (1)

Publication Number Publication Date
EE200300456A true EE200300456A (et) 2004-02-16

Family

ID=23063451

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300456A EE200300456A (et) 2001-03-22 2002-03-22 Indolopürrolokarbasoolide topoisomeraas I selektiivsed tsütotoksilised suhkruderivaadid ning nende kasutamine

Country Status (22)

Country Link
US (1) US6855698B2 (no)
EP (1) EP1370673A4 (no)
JP (1) JP2004534006A (no)
KR (1) KR20030085035A (no)
CN (1) CN1509335A (no)
BG (1) BG108183A (no)
BR (1) BR0208322A (no)
CA (1) CA2441412A1 (no)
CZ (1) CZ20032876A3 (no)
EE (1) EE200300456A (no)
HR (1) HRP20030761A2 (no)
HU (1) HUP0400265A2 (no)
IL (1) IL157909A0 (no)
IS (1) IS6958A (no)
MX (1) MXPA03008589A (no)
NO (1) NO20034190L (no)
PL (1) PL368942A1 (no)
RU (1) RU2003131269A (no)
SK (1) SK12022003A3 (no)
WO (1) WO2002077255A1 (no)
YU (1) YU74103A (no)
ZA (1) ZA200307317B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487925A (en) 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation
US4552842A (en) 1983-01-28 1985-11-12 Bristol-Myers Company Process for producing rebeccamycin
US4567143A (en) 1984-09-04 1986-01-28 Bristol-Myers Company Process for preparing 4'-deschlororebeccamycin
US4785085A (en) 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
WO1989007105A1 (en) 1988-02-04 1989-08-10 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
DE3803620A1 (de) 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE3924538A1 (de) 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung
US5618809A (en) 1989-12-14 1997-04-08 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes copiosa subsp. nov SCC 1951 ATCC 53856
IL97233A (en) 1990-03-06 1995-03-30 Bristol Myers Squibb Co Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them
US5478813A (en) 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
US5589365A (en) * 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
NZ245203A (en) 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5668271A (en) 1991-11-29 1997-09-16 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
DE69331228D1 (en) 1992-09-21 2002-01-10 Kyowa Hakko Kogyo Kk Heilmittel für thrombozytopenia
FR2696465B1 (fr) 1992-10-02 1994-12-23 Adir Nouveaux dérivés d'ellipticine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
JP3603322B2 (ja) 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
US5468872A (en) 1993-09-16 1995-11-21 Cephalon, Inc. K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders
WO1995030682A1 (fr) 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Derive d'indolopyrolocarbazole antitumoral
WO1996004293A1 (fr) 1994-08-02 1996-02-15 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazoles antitumoraux
US5475110A (en) 1994-10-14 1995-12-12 Cephalon, Inc. Fused Pyrrolocarbazoles
US5705511A (en) 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
WO1997007081A2 (en) 1995-08-11 1997-02-27 Yale University Glycosylated indolocarbazole synthesis
JP2000516250A (ja) * 1996-08-22 2000-12-05 ブリストルーマイヤーズ スクイブ カンパニー インドロピロロカルバゾールの細胞毒性アミノ糖および関連する糖誘導体
CO4940430A1 (es) 1997-07-07 2000-07-24 Novartis Ag Compuestos policiclicos que contienen estaurosporina hidrogenada con propiedades farmacologicas convenientes y un efecto inhibidor sobre el crecimiento de las celulas tumorales
FR2801054B1 (fr) 1999-11-17 2003-06-13 Adir Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
HUP0400265A2 (hu) 2004-08-30
SK12022003A3 (sk) 2004-05-04
EP1370673A4 (en) 2006-08-09
EP1370673A1 (en) 2003-12-17
US6855698B2 (en) 2005-02-15
NO20034190D0 (no) 2003-09-19
US20030083271A1 (en) 2003-05-01
HRP20030761A2 (en) 2004-04-30
JP2004534006A (ja) 2004-11-11
RU2003131269A (ru) 2005-05-10
NO20034190L (no) 2003-11-19
MXPA03008589A (es) 2003-12-08
IS6958A (is) 2003-09-16
IL157909A0 (en) 2004-03-28
YU74103A (sh) 2006-05-25
PL368942A1 (en) 2005-04-04
KR20030085035A (ko) 2003-11-01
WO2002077255A1 (en) 2002-10-03
CA2441412A1 (en) 2002-10-03
CN1509335A (zh) 2004-06-30
BG108183A (en) 2004-07-30
BR0208322A (pt) 2004-10-13
CZ20032876A3 (en) 2004-03-17
ZA200307317B (en) 2004-12-20

Similar Documents

Publication Publication Date Title
IS7079A (is) Fenýlsúlfónýl-1,3-díhýdró-2H-indól-2-ón afleiður,framleiðsla þeirra og notkun í meðferðarskyni
EE200400059A (et) Diarüültsükloalküülderivaadid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
NO20041975D0 (no) Bicyklisk oksopyridin og oksopyrimidinderivater
PT1268480E (pt) Derivados de 8-quinolinil-xantina e 8-isoquinolinil-xantina como inibidores da pde 5
EE200300544A (et) 4-anilinokinoliin-3-karboksamiidid, nende kasutamine ning valmistamine
NO20054715L (no) Fremgangsmater og mellomprodukter for fremstilling av anti-cancer forbindelser
EE200300207A (et) Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
EE200300320A (et) Meetod epotilooni analoogi valmistamiseks parenteraalseks manustamiseks ning kasutamine
AU2003284808A8 (en) The derivatives of pyridone and the use of them
ATE390426T1 (de) Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
EP1539692A4 (en) FURANO DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
EE200200607A (et) 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena
DK1537096T3 (da) Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
NO20031701D0 (no) Fremgangsmåte og mellomprodukter i fremstilling av 7- substituerte antiöstrogener
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20040726L (no) Kombinasjonspreparater av arylsubstituerte propanolaminderivater med andre aktive forbindelser og anvendelse derav.
BR0208566B1 (pt) Derivados de Beta-Carbolina, Seu Uso, e composição Farmacêutica
ITMI991483A0 (it) Derivati tassanici e procedimenti per la loro preparazione
IS2331B (is) 2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og meðferðarfræðileg notkun þeirra
EE200300456A (et) Indolopürrolokarbasoolide topoisomeraas I selektiivsed tsütotoksilised suhkruderivaadid ning nende kasutamine
FR2814167B1 (fr) Preparation de la camptothecine et de ses derives
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina
EE200300436A (et) Imidasolidiini derivaadid, nende valmistamine ja kasutamine põletikuvastaste toimeainetena ning neid sisaldav ravimpreparaat
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks